Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9692029 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Conditions: Glaucoma;   Periocular Skin Pigmentation Changes
Interventions: Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost

Indicates status has not been verified in more than two years